CRT 2025
CRT Debate Series
Sunday Session
Allen Jeremias, MD, FSCAI
Associate Director, Cardiac Cath Lab
St. Francis Hospital, Roslyn, NY
Woodbury, New York, United States
Disclosure information not submitted.
Ziad Ali, MD, DPhil
Director
DeMatteis Cardiovascular Institute
Columbia University
Roslyn, New York, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Abiomed: Grant/Research Support (Ongoing); Acist Medical: Grant/Research Support (Ongoing); AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); Cardiovascular Systems Inc: Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elucid BioImaging: Stock-privately held company (Ongoing); NIH: Grant/Research Support (Ongoing); Opsens: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips; Abbott: Grant/Research Support (Ongoing); SpectraWAVE, Inc: Stock-privately held company (Ongoing); Teleflex: Grant/Research Support (Ongoing)
William F. Fearon, MD
Professor of Medicine
Director, Interventional Cardiology
Stanford University School of Medicine
Stanford, California, United States
No relationships to disclose
Morton J. Kern, MD, MSCAI, FACC, FAHA
Interventional Cardiologist
VA Long Beach Health Care System
Long Beach, California, United States
No relationships to disclose